Clinical Trials Directory

Trials / Completed

CompletedNCT01645397

Exhaled Nitric Oxide and Airway Caliber in Children With Asthma

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Atlantic Health System · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess if in steroid naïve asthmatic children with elevated baseline exhaled nitric oxide, treatment with inhaled steroid and normalization of exhaled nitric oxide level results in restoration of the bronchodilator response to deep inhalation.

Detailed description

Previous studies have shown that a deep inhalation (DI) would increase airway caliber in normal subjects. Whereas in asthmatics with spontaneous bronchoconstriction (obstruction of the airway), DI was shown to worsen airway obstruction. The mechanism for this variability in response to DI is not well-understood, but seems to be a key in understanding the pathophysiology of the disease, and possibly in the development of an effective therapy. Air way inflammation resulting in airway wall thickening and peribronchial edema is thought to play a role how the airway responds to deep inhalation. This study assess if reduction in airway inflammation (as measured by level of exhaled NO)results in optimization of the bronchodilator response to deep inhalation

Conditions

Timeline

Start date
2011-06-01
Primary completion
2013-06-01
Completion
2013-08-01
First posted
2012-07-20
Last updated
2014-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01645397. Inclusion in this directory is not an endorsement.